Safety and Effectiveness Study of the TOPS System, a Total Posterior Arthroplasty Implant Designed to Alleviate Pain Resulting From Moderate to Severe Lumbar Stenosis
A Prospective, Multi-Center Clinical Study to Assess the Saftey and Effectiveness of the Impliant TOPS System
1 other identifier
interventional
450
1 country
16
Brief Summary
The purpose of this multi-center, randomized, clinical study is to establish the safety and effectiveness of the TOPS™ System, used following decompression, in the treatment of lower back and leg pain with, or without spinal claudication, that results from moderate or severe lumbar spinal stenosis at one vertebral level between L3 and L5.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for phase_3 low-back-pain
16 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2006
CompletedFirst Submitted
Initial submission to the registry
November 29, 2006
CompletedFirst Posted
Study publicly available on registry
November 30, 2006
CompletedMay 18, 2011
January 1, 2010
November 29, 2006
May 17, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (6)
Primary safety and effectiveness to determine patient success are: 1 .15% ODI improvement vs baseline at 24 mos; 20 mm leg and back pain VAS improvement vs baseline at 24 mos.
2. improvement of at least 20 mm in leg pain at 24 months compared to baseline using a VAS pain scale;
3. maintenance or improvement of neurological status;
4. no revisions, supplemental fixation, and removals;
5. absence of major device-related complications (device component degradation or breakage, device component separation or disassembly, device component loosening (including screw loosening)) requiring revisions, supplemental fixation, and removals;
6. absence of spontaneous fusion in the investigational group and lack of fusion in the control
Secondary Outcomes (4)
Secondary outcome measurements that will be assessed include: 1. Zurich Claudication Questionaire scores, SF-36 scores, and VAS back pain score
2. Adverse events
3. time to recovery, work status, OR time, blood loss, and pharmaceutical use
4. radiographic measurements (degree of stenosis & spondylolisthesis, disc height, disc angle, alignment, translational motions, Range of Motion (affected level and entire lumbar spine), disc health (affected & adjacent levels), fusion status.
Interventions
Eligibility Criteria
You may qualify if:
- Moderate to Severe lumbar spinal stenosis at a single level\* between L3 - L5, with radiographic confirmation of any one of the following on CT, MRI, plain x-ray or myelography:
- Evidence of thecal sac and/or cauda equina compression
- Evidence of nerve root impingement by either osseous or non-osseous elements;
- Evidence of hypertrophic facets with canal encroachment Moderate/severe spinal stenosis is further defined radiographically as;
- moderate canal stenosis is a 25-49% reduction in the A/P dimension of the central and/or lateral foramen when compared to adjacent (cephlad) level
- Severe canal stenosis is defined as 50% or greater reduction in the A/P dimension of the central and/or lateral foramen when compared to the adjacent (cephlad) level \*\*Patients which require minimal decompressive surgery at an adjacent level, may have a laminonotmy or soft tissue resection as long as the decompression does not compromise the stability of the adjacent segment.
- At least six (6) months of failed, conservative treatment prior to surgery, including physical therapy, use of anti-inflammatory medications at maximum specified dosage; administration of epidural/facet injections.
- Age 40-75 years old (male or female).
- Up to one prior surgery without instrumentation implanted at any lumbar vertebral level limited to the following:
- IDET,
- laminotomy,
- laminectomy,
- foraminotomy
- Discectomy (that occurred at least three years ago without any reoccurrence of herniation)
- Lower back pain and/or sciatica with or without spinal claudication.
- +2 more criteria
You may not qualify if:
- Back or non-radicular leg pain of unknown etiology
- Spondylolisthesis Grade II or higher
- Stenosis caused by an extruded spinal disc fragment
- Lytic spondylolisthesis
- Known allergy to titanium and/or polyurethane
- Prior fusion surgery at any lumbar vertebral level with or without instrumentation
- Supplemental interbody support required (e.g., bone graft, spacers, VBRs, or fusion cages)
- Clinically compromised vertebral bodies at the affected level(s) due to any traumatic, neoplastic, metabolic or infectious pathology.
- Scoliosis of greater than ten (10) degrees (both angular and rotational)
- Morbid obesity defined as a body mass index \> 40 or a weight more than 100 lbs. over ideal body weight.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Impliant, Ltd.lead
Study Sites (16)
Institute for Advanced Spinal Research In California
Beverly Hills, California, 90211, United States
Century City Doctors Hospital
Beverly Hills, California, 90212, United States
Seton Medical Center
Daly City, California, 94015, United States
Yale University - School of Medicine
New Haven, Connecticut, 06519, United States
The Orthopaedic & Sports Medicine Ctr.
Trumbull, Connecticut, 06611, United States
Florida Orthopaedic Institute
Tampa, Florida, 33637, United States
Illinois Neuro Spine Center
Ogden, Illinois, 60504, United States
Saint Joseph Medical Center & Orthopaedic Associates
Baltimore, Maryland, 21204, United States
The Boston Spine Group
Boston, Massachusetts, 02120, United States
New England Neuro Assoc.
Springfiled, Massachusetts, 01104, United States
Columbia Orthopedic Group
Columbia, Missouri, 65201, United States
Orthopedic Spine Care of Long Island
Huntington Station, New York, 11746, United States
Buffalo Spine Surgery
Lockport, New York, 14094, United States
Carolinas Medical Center Hospital - Neurosurgery & Spine Associates
Charlotte, North Carolina, 28204, United States
NeuroSpine Center of Wisconsin
Appleton, Wisconsin, 54913, United States
Milwaukee Spinal Specialists
Milwaukee, Wisconsin, 53211, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Paul McAfee, M.D.
Orthopaedic Associates, P.A
Study Design
- Study Type
- interventional
- Phase
- phase 3
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
November 29, 2006
First Posted
November 30, 2006
Study Start
September 1, 2006
Last Updated
May 18, 2011
Record last verified: 2010-01